Atlas Trials

An Observational Study to Assess the Impact of Upadacitinib in Adult Hungarian Participants With Moderate to Severe Rheumatoid Arthritis (RA) in Real-World Practice

Clinical trial NCT05327920 · COMPLETED

Trial details

NCT number
NCT05327920
Sponsor
AbbVie
Status
COMPLETED
Study type
OBSERVATIONAL
Rheumatoid Arthritis
Start date
2022-04-20
Primary completion
2024-04-22
Enrollment
93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.